Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19, An early investigation from exposure to treatment outcomes in Tehran, Iran.
Ashraf MA, Shokouhi N, Shirali E, Davari-Tanha F, Shirani K, Memar O, Kamalipour A, Azarnoush A, Mabadi A, Ossareh A, Sanginabadi M, Azad TM, Aghaghazvini L, Ghaderkhani S, Poordast T, Pourdast A, Nazemi P. Ashraf MA, et al. Among authors: ghaderkhani s. J Res Med Sci. 2021 Nov 29;26:114. doi: 10.4103/jrms.JRMS_1088_20. eCollection 2021. J Res Med Sci. 2021. PMID: 35126577 Free PMC article.
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir.
Rahmani H, Davoudi-Monfared E, Nourian A, Nabiee M, Sadeghi S, Khalili H, Abbasian L, Ghiasvand F, Seifi A, Hasannezhad M, Ghaderkhani S, Mohammadi M, Yekaninejad MS. Rahmani H, et al. Among authors: ghaderkhani s. Daru. 2020 Dec;28(2):625-634. doi: 10.1007/s40199-020-00369-2. Epub 2020 Aug 28. Daru. 2020. PMID: 32857301 Free PMC article.
The association between the level of serum 25(OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection: A case-control study of hospitalized patients in Tehran, Iran.
Abdollahi A, Kamali Sarvestani H, Rafat Z, Ghaderkhani S, Mahmoudi-Aliabadi M, Jafarzadeh B, Mehrtash V. Abdollahi A, et al. Among authors: ghaderkhani s. J Med Virol. 2021 Apr;93(4):2359-2364. doi: 10.1002/jmv.26726. Epub 2020 Dec 29. J Med Virol. 2021. PMID: 33314166
Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial.
JamaliMoghadamSiahkali S, Zarezade B, Koolaji S, SeyedAlinaghi S, Zendehdel A, Tabarestani M, Sekhavati Moghadam E, Abbasian L, Dehghan Manshadi SA, Salehi M, Hasannezhad M, Ghaderkhani S, Meidani M, Salahshour F, Jafari F, Manafi N, Ghiasvand F. JamaliMoghadamSiahkali S, et al. Among authors: ghaderkhani s. Eur J Med Res. 2021 Feb 11;26(1):20. doi: 10.1186/s40001-021-00490-1. Eur J Med Res. 2021. PMID: 33573699 Free PMC article. Clinical Trial.
Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study.
SeyedAlinaghi S, Abbasian L, Solduzian M, Ayoobi Yazdi N, Jafari F, Adibimehr A, Farahani A, Salami Khaneshan A, Ebrahimi Alavijeh P, Jahani Z, Karimian E, Ahmadinejad Z, Khalili H, Seifi A, Ghiasvand F, Ghaderkhani S, Rasoolinejad M. SeyedAlinaghi S, et al. Among authors: ghaderkhani s. Eur J Med Res. 2021 May 6;26(1):41. doi: 10.1186/s40001-021-00513-x. Eur J Med Res. 2021. PMID: 33957992 Free PMC article.
Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19.
Abbasian L, Toroghi N, Rahmani H, Khalili H, Hasannezhad M, Ghiasvand F, Jafari S, Salehi M, Salahshour F, Azadbakhsh Kanaf Gorabi M, Alizade F, Ghaderkhani S, Nakhostin M. Abbasian L, et al. Among authors: ghaderkhani s. Int Immunopharmacol. 2022 Jun;107:108689. doi: 10.1016/j.intimp.2022.108689. Epub 2022 Mar 17. Int Immunopharmacol. 2022. PMID: 35313272 Free PMC article.
Rapid Detection Test for COVID-19 among Healthcare Workers and the Role of Personal Protective Equipment.
Hajiabdolbaghi M, Aryannejad A, Tabary M, Farhangi P, Abdollahi A, Ghaderkhani S, Amini M, Kimyaee E, Ranjbar A, Salehi M, Ghiasvand F, Meidani M, Hasannezhad M, Mohammadnejad E, Hadipour M, Araghi F, Mashinchi B, Seifi A. Hajiabdolbaghi M, et al. Among authors: ghaderkhani s. Arch Iran Med. 2022 Feb 1;25(2):91-97. doi: 10.34172/aim.2022.15. Arch Iran Med. 2022. PMID: 35429945 Free article.
Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study.
Khorshiddoust RR, Khorshiddoust SR, Hosseinabadi T, Mottaghitalab F, Mokhtari F, Azadinia F, Mozdarani H, Shabani M, Emadi-Kouchak H, Taheri B, Khani-Juyabad F, Kashani MA, Sadoughi A, Zamanizadeh S, Maddah H, Aminzadeh M, Khanaki M, Saremi S, Rad AP, Fatehi A, Rad MG, Haftbaradaran M, Khosroshahi M, Sadeghi M, Aminnayeri M, Jafari S, Ghiasvand F, Seifi A, Ghaderkhani S, Manshadi SAD, Salehi M, Abbasian L, Hasannezhad M, Meidani M, Hajiabdolbaghi M, Ahmadinejad Z, Parash M, Sedighi Z, Mohammadian A. Khorshiddoust RR, et al. Among authors: ghaderkhani s. Biomed Pharmacother. 2022 May;149:112729. doi: 10.1016/j.biopha.2022.112729. Epub 2022 Feb 17. Biomed Pharmacother. 2022. PMID: 35276467 Free PMC article. Clinical Trial.
18 results